Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Understanding the C-pulse device and its potential to treat heart failure.

Literature DB >> 20425494

Understanding the C-pulse device and its potential to treat heart failure.

Abstract

The Sunshine Heart C-Pulse (C-Pulse; Sunshine Heart Inc., Tustin, CA) device is an extra-aortic implantable counterpulsation pump designed as a non-blood contacting ambulatory heart assist device, which may provide relief from symptoms for class II-III congestive heart failure patients. It has a comparable hemodynamic augmentation to intra-aortic balloon counterpulsation devices. The C-Pulse cuff is implanted through a median sternotomy, secured around the ascending aorta, and pneumatically driven by an external system controller. Pre-clinical studies in the acute pig model, and initial temporary clinical studies in patients undergoing off-pump coronary bypass surgery have shown substantial increase in diastolic perfusion of the coronary vessels, which translated to a favorable improvement in ventricular function. A U.S. prospective multi-center trial to evaluate the safety and efficacy of the C-Pulse in class III patients with moderate heart failure is now in progress.

Entities: Disease Species

Mesh：

Year: 2010 PMID： 20425494 DOI： 10.1007/s11897-010-0007-7

Source DB: PubMed Journal: Curr Heart Fail Rep ISSN： 1546-9530

11 in total

1. Long-term use of a left ventricular assist device for end-stage heart failure.

Authors: E A Rose; A C Gelijns; A J Moskowitz; D F Heitjan; L W Stevenson; W Dembitsky; J W Long; D D Ascheim; A R Tierney; R G Levitan; J T Watson; P Meier; N S Ronan; P A Shapiro; R M Lazar; L W Miller; L Gupta; O H Frazier; P Desvigne-Nickens; M C Oz; V L Poirier
Journal: N Engl J Med Date: 2001-11-15 Impact factor: 91.245

2. Cardiac resynchronization in chronic heart failure.

Authors: William T Abraham; Westby G Fisher; Andrew L Smith; David B Delurgio; Angel R Leon; Evan Loh; Dusan Z Kocovic; Milton Packer; Alfredo L Clavell; David L Hayes; Myrvin Ellestad; Robin J Trupp; Jackie Underwood; Faith Pickering; Cindy Truex; Peggy McAtee; John Messenger
Journal: N Engl J Med Date: 2002-06-13 Impact factor: 91.245

3. Origins of intraaortic balloon pumping.

Authors: A Kantrowitz
Journal: Ann Thorac Surg Date: 1990-10 Impact factor: 4.330

4. Beat-to-beat augmentation of left ventricular function by intraaortic counterpulsation.

Authors: A T Cheung; J S Savino; S J Weiss
Journal: Anesthesiology Date: 1996-03 Impact factor: 7.892

5. Relation of hemodynamic variables to augmentation of left anterior descending coronary flow by intraaortic balloon pulsation in coronary artery disease.

Authors: M Zehetgruber; G Mundigler; G Christ; C Merhaut; U Klaar; C Kratochwill; T Neunteufl; S Hofmann; G Heinz; G Maurer; P Siostrzonek
Journal: Am J Cardiol Date: 1997-10-01 Impact factor: 2.778

6. Initial clinical experience with intraaortic balloon pumping in cardiogenic shock.

Authors: A Kantrowitz; S Tjonneland; P S Freed; S J Phillips; A N Butner; J L Sherman
Journal: JAMA Date: 1968-01-08 Impact factor: 56.272

7. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay.

Authors: S Cazeau; C Leclercq; T Lavergne; S Walker; C Varma; C Linde; S Garrigue; L Kappenberger; G A Haywood; M Santini; C Bailleul; J C Daubert
Journal: N Engl J Med Date: 2001-03-22 Impact factor: 91.245

8. Extra-ascending aortic versus intra-descending aortic balloon counterpulsation-effect on coronary artery blood flow.

Authors: Andrew N Davies; William S Peters; Tonglin Su; Colin E Sullivan; Theo Perkidides; F Paget Milsom; Geoffrey White
Journal: Heart Lung Circ Date: 2005-07-25 Impact factor: 2.975

9. Incidence and patterns of adverse event onset during the first 60 days after ventricular assist device implantation.

Authors: Elizabeth A Genovese; Mary Amanda Dew; Jeffrey J Teuteberg; Marc A Simon; Joy Kay; Michael P Siegenthaler; Jay K Bhama; Christian A Bermudez; Kathleen L Lockard; Steve Winowich; Robert L Kormos
Journal: Ann Thorac Surg Date: 2009-10 Impact factor: 4.330

Understanding the C-pulse device and its potential to treat heart failure.

1. Long-term use of a left ventricular assist device for end-stage heart failure.

2. Cardiac resynchronization in chronic heart failure.

3. Origins of intraaortic balloon pumping.

4. Beat-to-beat augmentation of left ventricular function by intraaortic counterpulsation.

5. Relation of hemodynamic variables to augmentation of left anterior descending coronary flow by intraaortic balloon pulsation in coronary artery disease.

6. Initial clinical experience with intraaortic balloon pumping in cardiogenic shock.

7. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay.

8. Extra-ascending aortic versus intra-descending aortic balloon counterpulsation-effect on coronary artery blood flow.

9. Incidence and patterns of adverse event onset during the first 60 days after ventricular assist device implantation.

10. Implantable LVAD infections: implications for permanent use of the device.

1. The future of adult cardiac assist devices: novel systems and mechanical circulatory support strategies.

2. Concept and first experimental results of a new ferromagnetic assist device for extra-aortic counterpulsation.

Review 3. Aortic counterpulsation: C-pulse and other devices for cardiac support.

4. Muscle-Powered Counterpulsation for Untethered, Non-Blood-Contacting Cardiac Support: A Path to Destination Therapy.

5. New developments in the surgical management of end-stage heart failure.

6. Preliminary Results From the C-Pulse OPTIONS HF European Multicenter Post-Market Study.